|
1
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ou DP, Yang LY, Huang GW, Tao YM, Ding X
and Chang ZG: Clinical analysis of the risk factors for recurrence
of HCC and its relationship with HBV. World J Gastroenterol.
11:2061–2066. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kolodkin AL, Matthes DJ, O'Connor TP,
Patel NH, Admon A, Bentley D and Goodman CS: Fasciclin IV:
Sequence, expression, and function during growth cone guidance in
the grasshopper embryo. Neuron. 9:831–845. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kolodkin AL, Matthes DJ and Goodman CS:
The semaphorin genes encode a family of transmembrane and secreted
growth cone guidance molecules. Cell. 75:1389–1399. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yazdani U and Terman JR: The semaphorins.
Genome Biol. 7:2112006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hung RJ, Yazdani U, Yoon J, Wu H, Yang T,
Gupta N, Huang Z, van Berkel WJ and Terman JR: Mical links
semaphorins to F-actin disassembly. Nature. 463:823–827. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ito T, Kagoshima M, Sasaki Y, Li C, Udaka
N, Kitsukawa T, Fujisawa H, Taniguchi M, Yagi T, Kitamura H, et al:
Repulsive axon guidance molecule Sema3A inhibits branching
morphogenesis of fetal mouse lung. Mech Dev. 97:35–45. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Maione F, Capano S, Regano D, Zentilin L,
Giacca M, Casanovas O, Bussolino F, Serini G and Giraudo E:
Semaphorin 3a overcomes cancer hypoxia and metastatic dissemination
induced by antiangiogenic treatment in mice. J Clin Invest.
122:1832–1848. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
10
|
Nasarre P, Gemmill RM and Drabkin HA: The
emerging role of class-3 semaphorins and their neuropilin receptors
in oncology. Onco Targets Ther. 7:1663–1687. 2014.PubMed/NCBI
|
|
11
|
Bagci T, Wu JK, Pfannl R, Ilag LL and Jay
DG: Autocrine semaphorin 3a signaling promotes glioblastoma
dispersal. Oncogene. 28:3537–3550. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Müller MW, Giese NA, Swiercz JM, Ceyhan
GO, Esposito I, Hinz U, Büchler P, Giese T, Büchler MW, Offermanns
S, et al: Association of axon guidance factor semaphorin 3a with
poor outcome in pancreatic cancer. Int J Cancer. 121:2421–2433.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhou H, Wu A, Fu W, Lv Z and Zhang Z:
Significance of semaphorin-3A and MMP-14 protein expression in
non-small cell lung cancer. Oncol Lett. 7:1395–1400.
2014.PubMed/NCBI
|
|
14
|
Blanc V, Nariculam J, Munson P, Freeman A,
Klocker H, Masters J and Williamson M: A role for class 3
semaphorins in prostate cancer. Prostate. 71:649–658. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Herman JG and Meadows GG: Increased class
3 semaphorin expression modulates the invasive and adhesive
properties of prostate cancer cells. Int J Oncol. 30:1231–1238.
2007.PubMed/NCBI
|
|
16
|
Rivera LB and Bergers G: Location,
location, location: Macrophage positioning within tumors determines
pro- or antitumor activity. Cancer Cell. 24:687–689. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Li Y, Tian B, Yang J, Zhao L, Wu X, Ye SL,
Liu YK and Tang ZY: Stepwise metastatic human hepatocellular
carcinoma cell model system with multiple metastatic potentials
established through consecutive in vivo selection and studies on
metastatic characteristics. J Cancer Res Clin Oncol. 130:460–468.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ye QH, Qin LX, Forgues M, He P, Kim JW,
Peng AC, Simon R, Li Y, Robles AI, Chen Y, et al: Predicting
hepatitis B virus-positive metastatic hepatocellular carcinomas
using gene expression profiling and supervised machine learning.
Nat Med. 9:416–423. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sun FX, Tang ZY, Lui KD, Ye SL, Xue Q, Gao
DM and Ma ZC: Establishment of a metastatic model of human
hepatocellular carcinoma in nude mice via orthotopic implantation
of histologically intact tissues. Int J Cancer. 66:239–243. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Dai Z, Zhou SL, Zhou ZJ, Bai DS, Xu XY, Fu
XT, Chen Q, Zhao YM, Zhu K, Yu L, et al: Capn4 contributes to
tumour growth and metastasis of hepatocellular carcinoma by
activation of the FAK-Src signalling pathways. J Pathol.
234:316–328. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Oliveri RS, Wetterslev J and Gluud C:
Hepatocellular carcinoma. Lancet. 380:470–471. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Villanueva A, Newell P, Chiang DY,
Friedman SL and Llovet JM: Genomics and signaling pathways in
hepatocellular carcinoma. Semin Liver Dis. 27:55–76. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Suzuki K, Kumanogoh A and Kikutani H:
Semaphorins and their receptors in immune cell interactions. Nat
Immunol. 9:17–23. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wang Y, He H, Srivastava N, Vikarunnessa
S, Chen YB, Jiang J, Cowan CW and Zhang X: Plexins are
GTPase-activating proteins for Rap and are activated by induced
dimerization. Sci Signal. 5:ra62012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Lepelletier Y, Smaniotto S, Hadj-Slimane
R, Villa-Verde DM, Nogueira AC, Dardenne M, Hermine O and Savino W:
Control of human thymocyte migration by
Neuropilin-1/Semaphorin-3A-mediated interactions. Proc Natl Acad
Sci USA. 104:pp. 5545–5550. 2007; View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Garcia F, Lepelletier Y, Smaniotto S,
Hadj-Slimane R, Dardenne M, Hermine O and Savino W: Inhibitory
effect of semaphorin-3A, a known axon guidance molecule, in the
human thymocyte migration induced by CXCL12. J Leukoc Biol.
91:7–13. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Westbrook JA, Cairns DA, Peng J, Speirs V,
Hanby AM, Holen I, Wood SL, Ottewell PD, Marshall H, Banks RE, et
al: CAPG and GIPC1: Breast cancer biomarkers for bone metastasis
development and treatment. J Natl Cancer Inst. 108:pii: djv3602016.
View Article : Google Scholar
|
|
28
|
Wang L and Guo XL: Molecular regulation of
galectin-3 expression and therapeutic implication in cancer
progression. Biomed Pharmacother. 78:165–171. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Tang D, Wang M, Sui A, Wang Y, Yang R,
Wang Z, Zhao Y, Jiao W and Shen Y: Prospective validation of
quantitative NSE mRNA in pleural fluid of non-small cell lung
cancer patients. Med Oncol. 30:6992013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Gires O and Bauerle PA: EpCAM as a target
in cancer therapy. JJ Clin Oncol. 28:e239–e242. 2010. View Article : Google Scholar
|
